Skip to main content

Table 1 Baseline characteristics

From: Crossing barriers: a multidisciplinary approach to children and adults with young-onset movement disorders

Patient characteristics

 

 Sex (male/female)

56/44

 Age (years)a

12.5 ± 6.3; 1–33

Age at symptom-onset (years)a

3.3 ± 4.6; 0–18

Duration of symptoms (years)a

9.2 ± 6.3; 1–32

Referral questions

 

 Movement disorder classification

50

 Etiology

38

 Treatment

42

MD classification

 

 Ataxia

9

 Dystonia

32

 Myoclonus

11

 Otherb

12

 Unclassified

36

Etiological diagnosis

 

Inherited etiologies

17

 Monogenic

 

  ARX mutation

1

  Ataxia telangiectasia

1

  Coffin Lowry syndrome

1

  Glutaric aciduria type 1

2

  GLI2 mutation

1

  GOSR2 mutation

1

  GTPCH deficiency (DYT5)

1

  Proprionacidemia

1

  SCN1A mutation

2

  THAP1 mutation (DYT6)

2

  TITF1 mutation

1

 Structural chromosomal abnormality

  Microdeletion 19p13.2p13.13 (NFIX and CACNA1A gene)

1

  Partial deletion chromosome 7q (SCGE gene)

1

  Uniparental disomia chromosome 7 (SCGE gene)

1

Acquired etiologies

12

  Infectious

2

  Perinatal asphyxia

9

  Functional

2

  1. aAge in years ± standard deviation; range
  2. bChorea, tics, tremor, parkinsonism and if no MD was present
  3. Abbreviations: ARX, Aristaless related homeobox; GOSR2, Golgi SNAP receptor complex member 2; GTPCH, Guanosine Triphosphate Cyclohydrolase; SCN1A, sodium channel voltage gated type I alpha subunit; TITF1, Thyroid transcription factor-1; NFIX, nuclear factor I/X; CACNA1A, calcium channel voltage-dependent, P/Q type, alpha 1A subunit; SCGE, epsilon-sarcoglycan